Literature DB >> 17067545

Lycopenoids: are lycopene metabolites bioactive?

Brian L Lindshield1, Kirstie Canene-Adams, John W Erdman.   

Abstract

In vitro lycopene is the most potent antioxidant among carotenoids. While antioxidant function may be relevant to health, we hypothesize that metabolites of lycopene may be bioactive and responsible for the beneficial effects of tomato product consumption. We term these metabolites "lycopenoids," which we believe may be produced from carotenoid monooxygenase (CMO) II, paralleling the production of retinoids from beta-carotene by CMO I. We present evidence suggesting that tomato carotenoid metabolites may be responsible for the reduced risk of prostate cancer seen in men consuming high levels of tomato products. Finally, we identify gaps in knowledge in this evolving area of carotenoid research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067545     DOI: 10.1016/j.abb.2006.09.012

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  32 in total

Review 1.  An update on the health effects of tomato lycopene.

Authors:  Erica N Story; Rachel E Kopec; Steven J Schwartz; G Keith Harris
Journal:  Annu Rev Food Sci Technol       Date:  2010

2.  Identification and quantification of apo-lycopenals in fruits, vegetables, and human plasma.

Authors:  Rachel E Kopec; Ken M Riedl; Earl H Harrison; Robert W Curley; Damian P Hruszkewycz; Steven K Clinton; Steven J Schwartz
Journal:  J Agric Food Chem       Date:  2010-03-24       Impact factor: 5.279

Review 3.  Lycopene metabolism and its biological significance.

Authors:  Xiang-Dong Wang
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

4.  Does lycopene offer human LDL any protection against myeloperoxidase activity?

Authors:  Poh Yeong Chew; Lucy Riley; Daniel L Graham; Khalid Rahman; Gordon M Lowe
Journal:  Mol Cell Biochem       Date:  2011-10-11       Impact factor: 3.396

5.  Nutritional aspects of phytoene and phytofluene, carotenoid precursors to lycopene.

Authors:  Nancy J Engelmann; Steven K Clinton; John W Erdman
Journal:  Adv Nutr       Date:  2011-01-10       Impact factor: 8.701

6.  Chemoprevention of prostate cancer with lycopene in the TRAMP model.

Authors:  Ramdev Konijeti; Susanne Henning; Aune Moro; Ahmed Sheikh; David Elashoff; Ari Shapiro; Melvin Ku; Jonathan W Said; David Heber; Pinchas Cohen; William J Aronson
Journal:  Prostate       Date:  2010-10-01       Impact factor: 4.104

Review 7.  Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids.

Authors:  Nancy E Moran; Emily S Mohn; Noor Hason; John W Erdman; Elizabeth J Johnson
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

8.  Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells.

Authors:  Fuzhi Lian; Xiang-Dong Wang
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

Review 9.  Are the health attributes of lycopene related to its antioxidant function?

Authors:  John W Erdman; Nikki A Ford; Brian L Lindshield
Journal:  Arch Biochem Biophys       Date:  2008-11-01       Impact factor: 4.013

10.  The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model.

Authors:  Krystle E Zuniga; Steven K Clinton; John W Erdman
Journal:  Cancer Prev Res (Phila)       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.